PLTP, the increased activity of which is known to be associated with atherosclerosis, systolic dysfunction, obesity, and diabetes (Chowaniec and Skoczyńska, 2018), was observed to be suppressed explicitly in all three IF groups. This evidence concerns the gene PLTP and obesity due to melanocortin 4 receptor deficiency.